Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NCCAM Advisory Council Approves Center's First Three Project Initiatives

This article was originally published in The Tan Sheet

Executive Summary

The newly chartered National Advisory Council for Complementary & Alternative Medicine unanimously approved a project proposal entitled "Traditional, Indigenous Systems of Medicine" at its inaugural meeting Aug. 31-Sept. 1 in Rockville, Md.
Advertisement

Related Content

St. John's Wort "SuperFluids" Manufacturing Method Receives NIH Grant
St. John's Wort "SuperFluids" Manufacturing Method Receives NIH Grant
St. John's Wort "SuperFluids" Manufacturing Method Receives NIH Grant
NCCAM St. John's wort study
NCCAM St. John's wort study
NCCAM St. John's wort study
Complementary Medicine Education MOU Signed By AHA, SUNY Stony Brook
Ginkgo Dementia Prevention Trial Will Be Funded With $15 Mil.
Ginkgo Dementia Prevention Trial Will Be Funded With $15 Mil.
NCCAM To Initiate Osteoarthritis Alt. Med. Clinical Trials With NIAMS

Topics

Advertisement
UsernamePublicRestriction

Register

PS090284

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel